VANCOUVER, British Columbia--(BUSINESS WIRE)--#LSBCawards--Life Sciences BC (LSBC) is pleased to announce the recipients of the 24th Annual Life Sciences BC Awards, presented by Farris. These awards recognize the achievements of individuals, companies, an
MISSISSAUGA, Ontario--(BUSINESS WIRE)--$MDX #SkinCancer--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX) is pleased to announce that it has made an amendment to the terms of the non-brokered Private Placement previously announced in its Ne
WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, Inc., a biopharmaceutical company leading a renaissance in the discovery and development of small molecule medicines by utilizing structural biology and a proprietary computational platform,
TORONTO--(BUSINESS WIRE)--Organic Potash Corporation (CSE: OPC) (“OPC” or the “Corporation”) announced today that the Corporation will undertake a non-brokered private placement to raise gross proceeds of up to $150,000 dollars at a price of $0.02
FORT LAUDERDALE, Fla. & TORONTO--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that at the Comp
Strategic alliance significantly expands ongoing multi-year collaboration by granting Turnstone broader access and enhanced benefits at Moffitt IND approval received for a Moffitt-sponsored Phase 1 study of TIDAL-01 in melanoma NEW YORK & TAMPA, Fla.--(
MONTREAL--(BUSINESS WIRE)--#DermatologyCRO--Innovaderm, a leading CRO in dermatology, has expanded its biometrics capacity following the acquisition of Excelsus Statistics, a Montreal-based company specialized in biostatistical and SAS programming service
LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough (“RCC”) and oth
Business basics become key skills for tomorrow’s top producers SASKATOON, Saskatchewan--(BUSINESS WIRE)--A new coaching program for Canadian farmers will empower producers to improve their finances, business risk management policies and, most important
BAAR, Switzerland--(BUSINESS WIRE)--Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced positive data from its EfficAPSI real-world study. Presented at the 2022 European Academy of Allergy and Clin
BAM's 2023 Most Promising Bioscience Student, Daniel Gussakovsky, and recent scholarship winner, shares about his research, why he's chosen it, and what he hopes to do in the future with it.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.